NIMSURA owner Contact Information online
from Ares Trading S.A.
NIMSURA
US serial number:85175933
Application filling date:Nov. 12, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jun. 23, 2014
Publication date:Mar. 22, 2011
Abandoned date:Jun. 23, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for human use, namely, preparations for the treatment of immunological diseases and disorders, inflammatory diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, rheumatological
Current owner owner name:Ares Trading S.A.
Current owner owner address:Zone Industrielle de l'Ouriettaz
Aubonne
SWITZERLAND
CH1170
Current owner legal entity type:société anonyme (sa)
Current owner state or country:SWITZERLAND
Attorney name:Robert B.G. Horowitz,
Attorney email:rhorowitz@bakerlaw.com
Attorney docket number:96307.314
Attorney email authorized:Yes
Correspondent name address:ROBERT B.G. HOROWITZ,
BAKER & HOSTETLER LLP
45 ROCKEFELLER PLZ
NEW YORK,
NEW YORK
UNITED STATES
10111-0230
Correspondent phone:212 589-4240
Correspondent email:rhorowitz@bakerlaw.com
Correspondent fax:212 589-4201
Correspondent email authorized:Yes
Domestic representative name:Robert B.G. Horowitz, Esq.
Domestic representative phone:212 589-4240
Domestic representative fax:212 589-4201
Domestic representative email:rhorowitz@bakerlaw.com
Domestic representative email authorized:Yes
Trademark staff tm attorney:CAPSHAW, DANIEL
Trademark staff law office assigned NIMSURA:LAW OFFICE 110
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (128) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) S. C. Johnson & Son, Inc. (30) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) Ares Trading S.A. (20) MONSTER ENERGY COMPANY (19) Scott Riddell (17)Popular publication dates
Mar. 22, 2011 Mar. 08, 2011 Mar. 15, 2011 Nov. 16, 2010 Apr. 12, 2011 Mar. 29, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
